Dapagliflozin Polpharma

Dapagliflozin Polpharma is an oral medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs known as SGLT2 inhibitors, which help the kidneys remove excess glucose from the body. This medication is manufactured by Zaklady Farmaceutyczne Polpharma S.A. in the EU.

Dapagliflozin Polpharma is primarily used to improve glycemic control in adults with type 2 diabetes. It works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys, which helps to increase the excretion of glucose through urine. This medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. People may wonder, 'What is Dapagliflozin used for?' It is not typically used for type 1 diabetes or diabetic ketoacidosis.

Common effects of Dapagliflozin Polpharma may include increased urination, which is a result of the medication's mechanism of action. Some users might experience symptoms such as thirst, dry mouth, or urinary tract infections. It is important to stay hydrated while taking this medication. Always consult a healthcare provider for personalized advice.

Dapagliflozin Polpharma should be handled with care, especially for individuals with a history of kidney problems or those who are dehydrated. It is crucial to follow the prescribed dosage and to monitor blood sugar levels regularly. Patients should also be aware of the signs of low blood sugar and take appropriate measures if they occur.

Dapagliflozin Polpharma may interact with certain medications, including diuretics, insulin, and other drugs that lower blood sugar. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated, as it can affect blood sugar levels and increase the risk of side effects.